GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » E10

Medexus Pharmaceuticals (TSX:MDP) E10 : C$-0.91 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medexus Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was C$-0.027. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-0.91 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-24), Medexus Pharmaceuticals's current stock price is C$1.63. Medexus Pharmaceuticals's E10 for the quarter that ended in Dec. 2023 was C$-0.91. Medexus Pharmaceuticals's Shiller PE Ratio of today is .


Medexus Pharmaceuticals E10 Historical Data

The historical data trend for Medexus Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals E10 Chart

Medexus Pharmaceuticals Annual Data
Trend Dec13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -1.23 -0.97

Medexus Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.16 -0.97 -0.95 -0.97 -0.91

Competitive Comparison of Medexus Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Medexus Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medexus Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medexus Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medexus Pharmaceuticals's Shiller PE Ratio falls into.



Medexus Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medexus Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.027/125.0724*125.0724
=-0.027

Current CPI (Dec. 2023) = 125.0724.

Medexus Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201312 -1.199 96.945 -1.547
201406 -0.152 99.473 -0.191
201409 -0.296 99.394 -0.372
201412 -0.298 98.367 -0.379
201503 -0.393 99.789 -0.493
201506 -0.299 100.500 -0.372
201509 -0.148 100.421 -0.184
201512 -0.296 99.947 -0.370
201603 0.226 101.054 0.280
201606 0.299 102.002 0.367
201609 -0.179 101.765 -0.220
201612 -0.149 101.449 -0.184
201703 -0.227 102.634 -0.277
201706 -0.215 103.029 -0.261
201709 -0.059 103.345 -0.071
201712 -0.173 103.345 -0.209
201803 -0.168 105.004 -0.200
201806 -0.120 105.557 -0.142
201809 -0.625 105.636 -0.740
201812 -0.099 105.399 -0.117
201903 0.027 106.979 0.032
201906 -0.152 107.690 -0.177
201909 0.040 107.611 0.046
201912 -0.192 107.769 -0.223
202003 -0.161 107.927 -0.187
202006 -0.325 108.401 -0.375
202009 -0.146 108.164 -0.169
202012 -1.127 108.559 -1.298
202103 -0.792 110.298 -0.898
202106 -0.415 111.720 -0.465
202109 0.659 112.905 0.730
202112 -0.090 113.774 -0.099
202203 -0.342 117.646 -0.364
202206 -0.090 120.806 -0.093
202209 -0.187 120.648 -0.194
202212 -0.095 120.964 -0.098
202303 0.465 122.702 0.474
202306 0.040 124.203 0.040
202309 -0.068 125.230 -0.068
202312 -0.027 125.072 -0.027

Add all the adjusted EPS together and divide 10 will get our e10.


Medexus Pharmaceuticals  (TSX:MDP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medexus Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Medexus Pharmaceuticals (TSX:MDP) Business Description

Traded in Other Exchanges
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.
Executives
Benoit Gravel Director